Rectal Adenocarcinoma — Trials

Rectal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

187 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 28
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03527784	Prestoma-Trial for Parastomal Hernia Prevention	terminated	N/A	14	University of OuluOTHER	1	Nov 5, 2018	clinicaltrials
NCT01887509	Evaluation of Rectal Tumor Margin Using Confocal Endomicroscopy and Comparison to Histopathology(TRaMA)	terminated	N/A	21	IHU StrasbourgOTHER	1	May 15, 2018	clinicaltrials